New rectal malaria drug could save kids in remote villages
NCT ID NCT06806956
First seen Feb 01, 2026 · Last updated May 10, 2026 · Updated 16 times
Summary
This study looks at whether giving a rectal medicine (rectal artesunate) followed by a 3-day course of artemisinin-based combination therapy (ACT) works as well as the standard injected treatment for severe malaria in children aged 6 months to 5 years. It involves over 2,000 children in Zambia and the Democratic Republic of Congo who live far from hospitals. The goal is to find a safe and effective way to treat severe malaria when quick referral to a health facility isn't possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tropical Diseases Research Centre
Ndola, Copperbelt, 10101, Zambia
-
University of Kinshasa
Kinshasa, Kinshasa City, Democratic Republic of the Congo
Conditions
Explore the condition pages connected to this study.